Clinical Study

Medical and Interventional Therapy for Spontaneous Vertebral Artery Dissection in the Craniocervical Segment

Table 1

Summary of characteristics of the 14 patients with SVAD treated by stenting.

PatientSexAgeHTFHSDMSigns/symptomsSVAD locationVA dominanceDevel of con-VANIHSSmRSFollow-up (months)

1m39A/N/T/V/HV3(L)/DoVA(−)206
2m38A/N/V/PV3(R)/DoVA(+)1012
3m41N/T/V/PV2(L)/DoVA(+)109
4m29A/N/VV2(R)/DoVA(+)1036
5m46A/N/T/VV3(R)/DoVA(+)1024
6m38A/N/V/PV3(L)/DoVA(+)1036
7m45A/N/T/HV2(L)/DoVA(+)1060
8f33D&DV3(L)/DoVA(+)3148
9m37A/N/T/VV3(R)/DoVA(+)1048
10m40A/N/PV2(L)/DocVA(−)1030
11f46A/N/T/HV3(R)/DoVA(+)1024
12m28A/T/HV2(L)/DoVA(+)1030
13m35A/N/T/HV3(L)/DoVA(+)1036
14m36A/V/HV2(L)/DoVA(+)1048

A: ataxia; N: nystagmus; T: tinnitus; V: vomiting; H: headache; P: neck pain; D&D: dysphagia and dysarthria; m: male; f: female; SVAD: spontaneous vertebral artery dissection; VA: vertebral artery; Devel of con-VA: development of contralateral vertebral artery distal to the orifice of PICA (posterior inferior cerebellar artery); NIHSS: National Institute of Health stroke scale; mRS: modified Rankin score; V3: the third segment of vertebral artery; V2: the second segment of vertebral artery; L: left; R: right; DoVA(+): dissection on the dominant vertebral artery; DoVA(−): dissection on the nondominant vertebral artery; HT: hypertension; FHS: family history of stroke; DM: diabetes mellitus.